Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report) was the recipient of a large drop in short interest in October. As of October 15th, there was short interest totalling 12,300 shares, a drop of 6.1% from the September 30th total of 13,100 shares. Based on an average daily trading volume, of 2,600 shares, the days-to-cover ratio is presently 4.7 days.
Guided Therapeutics Stock Up 25.0 %
Guided Therapeutics stock opened at $0.20 on Friday. Guided Therapeutics has a 52 week low of $0.06 and a 52 week high of $0.25. The company’s 50 day moving average price is $0.16 and its two-hundred day moving average price is $0.13. The stock has a market cap of $12.20 million, a P/E ratio of -6.67 and a beta of 0.52.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.01) earnings per share (EPS) for the quarter.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Read More
- Five stocks we like better than Guided Therapeutics
- Breakout Stocks: What They Are and How to Identify Them
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- What is Put Option Volume?
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- With Risk Tolerance, One Size Does Not Fit All
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
